… in COVID-19 The probable unhelpful property of corticosteroids, in the management of
COVID-19, … Corticosteroids play a key role in immunity and inflammation, especially at low doses. …

… , particularly at the moment, the COVID-19 virus. Chest CT may show … pneumonitis caused
by MTX consists of its definitive withdrawal and the use of oral or intravenous corticosteroids…

… The use of highly dosed corticosteroids was surrounded by similar controversy. They might
attenuate the “cytokine release syndrome” in the most severely affected patients. Others …

… initiation of steroids for post-COVID-19 pneumonitis with gradual improvements in clinical …
of post-COVID-19 pneumonitis and to assess the net benefit of prolonged corticosteroids in …

… benefits for critically ill COVID-19 patients receiving dexamethasone or tocilizumab, …
pneumonitis, which now is more relevant than ever with the rise in immune-mediated pneumonitis …

… The acute respiratory distress syndrome (ARDS) due to viral pneumonitis is one of the …
methyl prednisolone in management of COVID 19 along with dexamethasone were included. The …

… inflammatory markers in treatment of hospitalized COVID-19 patients. The latter findings are
consistent with our study as the use of pulse corticosteroids was superior to the conventional …

… with laboratory confirmed COVID-19 and pneumonitis as … The COVID-19 treatment strategy
evolved over time and … different groups according to COVID-19 treatment regimens: (1) …

… with infections as viral pneumonitis, bacterial pneumonia or bacteremia, and with
hyperglycemia (Supporting Information: Table S7). Infections among viral pneumonitis, bacterial …

… The routine use of systemic corticosteroids among severe and critical COVID-19 patients …
systemic corticosteroids on clinical outcomes in 1514 severe and 249 critical COVID-19 cases …